Dedicated to constant improvement in healthcare, our team commits to overcoming challenges and advancing medical technology for a positive impact on people's lives.
Upholding excellence and ethical standards in every facet of our work, ensuring precision and reliability from idea inception to solution execution.
Innovating with a compassionate approach, we develop advanced medical solutions that prioritize the well-being of individuals facing health challenges.
Prioritizing safety in all our endeavors, from conceptualization to implementation, ensuring our medical solutions adhere to the highest standards of quality and security.
Embracing transparency and openness in our operations, fostering trust and clear communication with our stakeholders and the wider community.
Demonstrating adaptable resilience in the face of challenges, we navigate obstacles with flexibility and determination, ensuring our innovations endure and thrive.
Ignacio is a recognized pediatric cardiac surgeon, known by his proactive and innovative profile. Author of multiple publications in peer-reviewed scientific journals, he pioneered surgical treatments for congenital heart diseases such as scimitar syndrome, atrioventricular septal defect, tetralogy of Fallot, aortic valve diseases, pulmonary valve regurgitation and single ventricle. He also serves as reviewer for prestigious international journals. He obtained his PhD in Medical Sciences in 2017 at the Favaloro University in Buenos Aires. After some years leading the congenital heart surgery at that institution, he came back to the public sector and became Head of Unit of Cardiac Surgery at the Children's Hospital of Buenos Aires "Dr. Pedro de Elizalde", his current position.
Among other awards, he has won IncuBAte and NAVES, and also received the official recognition of the Buenos Aires City Government as Prominent Figure of Medical Sciences.
Tomas brings extensive experience as a Business Strategy Consultant. Before co-founding AVaTAR MedTech, he led the development of Omnichannel strategy and agile POD setup for a multinational pharmaceutical firm in LATAM. He distinguished himself by devising commercial strategies for a local medical supplier in Argentina. Subsequently, his role expanded to that of a Commercial Project Management Officer and methodologies expert, playing a crucial role in launching a NewCo for a major energy player in Argentina.
Tomas has also made significant contributions to local mass consumption analysis, leveraging his Spanish-English fluency to engage with diverse stakeholders. His expertise encompasses Life Sciences, Medical Devices, Pharma, and Consulting.
At AVaTAR MedTech, we embrace the UN Sustainable Development Goals. Our innovations not only enhance health but also propel us toward a more sustainable and equitable future. Join us in our mission for a healthier, responsible world.
Our devices are life-changing and life-saving technology. This innovation is a pivotal breakthrough for individuals who have faced disabilities since childhood or adulthood, empowering them to lead active and productive lives. Moreover, in the most critical situations, it has the potential to save lives, thereby impacting millions of families globally. This technology not only enhances individual well-being but also profoundly changes the lives of many around the world.
Understanding the prevalence and annual incidence of aortic and pulmonary valve diseases, as well as the significant number of individuals requiring surgical treatment, highlights the importance of innovation in medical technology. This innovation is crucial for ensuring the availability of adequate medical resources. These include trained surgeons, advanced facilities, and specialized procedures designed to meet the needs of this global population in a standardized and sustainable manner.
Thanks to our medical devices, we anticipate that the surgical approach will improve and broaden access to treatment by identifying and catering to an underserved demand. From a medical perspective, this device broadens the scope of surgical options through its cost-effectiveness, exceptional ease of use, and efficacy. As a result, a significant number of new patients will gain the chance to qualify for aortic or pulmonary valve surgery and undergo this innovative procedure.
.png)